Treatment failure resulting from resistance of staphylococcus aureus to daptomycin.

Skiest, Daniel, MD

Publication date

February 2006

Publisher

Scholarly Commons @ Baystate Health

Abstract

Daptomycin, a new cyclic lipopeptide, was recently approved for the treatment of infections by gram-positive organisms, including infections with methicillin-resistant Staphylococcus aureus (MRSA). A patient infected with infected with MRSA developed res

Extracted data

We use cookies to provide a better user experience.

Data Protection

Treatment failure resulting from resistance of staphylococcus aureus to daptomycin.

Abstract

Extracted data

Treatment failure resulting from resistance of staphylococcus aureus to daptomycin.

Abstract

Extracted data

Related items

Related items